Clinical Trials Arena February 20, 2025
Abigail Beaney

The FDA, NIH and CDC has cut 5,200 probationary staff in a job cull across the HHS over the Valentine’s Day weekend.

Figures from across the pharmaceutical and medtech industry have spoken out on social media following the culling of staff at US healthcare agencies, with many sharing their dismay and fear about the impact it could have on device and drug approvals.

Last weekend, over 5,200 probationary staff from agencies within the Department of Health and Human Services (HHS), including staff from the US Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC) and the National Institute of Health (NIH), were hit by job cuts due to Department of Government Efficiency (DOGE) cutbacks.

The CDC’s...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, HHS, Medical Devices, Pharma, Pharma / Biotech
Medical device cybersecurity could be challenged by HHS staffing cuts
Lantheus completes acquisition of radiopharma firm Evergreen Theragnostics for up to $1B
Medical device industry projected to grow 9.8% from 2024 through 2029
3 takeaways from ACC 2025
Why A Security-First Approach Is Essential For Advancing MedTech

Share This Article